CytoMed Therapeutics: An Innovative Immunology Biotech Company To Watch (NASDAQ:GDTC)

Lymphocytes , t cells or cancer cells

Design Cells/iStock via Getty Images

CytoMed Therapeutics (NASDAQ:GDTC)

CytoMed Therapeutics (GDCT, or the Company), a Singapore-based biotechnology company trading on the NASDAQ, is developing multiple gamma delta chimeric antigen receptor T-cell (“γδ CAR-T”) therapeutics for the treatment of cancer. The Company is one of many who

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *